Comparing Anoro Ellipta vs Stiolto Respimat
| Anoro Ellipta (umeclidinium / vilanterol) | Stiolto Respimat (olodaterol / tiotropium) |
|
|---|
| Anoro Ellipta (umeclidinium / vilanterol) | Stiolto Respimat (olodaterol / tiotropium) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Anoro Ellipta is a once-daily inhalation that may be used to help maintain airway opening in adults with COPD. It is well-tolerated with few side effects, but it should not be used to treat asthma... View more |
Prescription only
Prescribed for COPD - Maintenance, COPD. Stiolto Respimat may also be used for purposes not listed in this medication guide. |
Related suggestions COPD
COPD, Maintenance
Popular comparisons
|
|||||||||||||||
| More about Anoro Ellipta (umeclidinium / vilanterol) | More about Stiolto Respimat (olodaterol / tiotropium) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Anoro Ellipta has an average rating of 7.1 out of 10 from a total of 69 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 22% reported a negative effect. |
Stiolto Respimat has an average rating of 7.3 out of 10 from a total of 48 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Anoro Ellipta side effects |
View all Stiolto Respimat side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Anoro Ellipta prices |
View all Stiolto Respimat prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
21.3 hours |
25 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 500 drugs are known to interact with Anoro Ellipta:
|
A total of 426 drugs are known to interact with Stiolto Respimat:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 18, 2013 |
May 21, 2015 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.